Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleNeuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.AuthorsPlasterer, Cody; Tsaih, Shirng-Wern; Peck, Amy R.; Chervoneva, Inna; O'Meara, Caitlin; Sun, Yunguang; Lemke, Angela; Murphy, Dana; Smith, Jennifer; Ran, Sophia; Kovatich, Albert J.; Hooke, Jeffrey A.; Shriver, Craig D.; Hu, Hai; Mitchell, Edith P.; Bergom, Carmen; Joshi, Amit; Auer, Paul; Prokop, Jeremy; Rui, HallgeirPublicationBreast Cancer Research & Treatment, 2019, Vol 177, Issue 1, p77ISSN0167-6806Publication typeArticleDOI10.1007/s10549-019-05307-8